Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

Description

The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.

Conditions

Skin Condition, Dermatology, Dermatology/Skin - Other

Study Overview

Study Details

Study overview

The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.

Application of the Belle.AI Dermatological Image Reference System on Patient Diagnosis Within an Active Clinical Setting

Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

Condition
Skin Condition
Intervention / Treatment

-

Contacts and Locations

Bronx

Urban Health Plan Inc., Bronx, New York, United States, 07059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient must present to walk-in clinic with a primary dermatological complaint.
  • * Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits.
  • * Participants must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture.
  • * Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator).
  • * Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

BelleTorus Corporation,

John Romano, MD, PRINCIPAL_INVESTIGATOR, BelleTorus Corporation

Franco Barsanti, PharmD, STUDY_DIRECTOR, Urban Health Plan Inc.

Study Record Dates

2025-06-30